When you come in for a consultation at ChiroHer, we'll take a thorough approach to understand your needs
India Demonstrates Strong Market Potential with Rising Obesity Prevalence Revenue from obesity GLP-1 treatment in India is expanding at a CAGR of 28.4%, supported by increasing obesity rates in metropolitan areas and growing awareness of cardiovascular risk factors
Statistical analyses Sample sizes were calculated based on power analyses for pharmacodynamic endpoints
Tell your healthcare provider if you have pancreas or kidney problems, type 2 diabetes, diabetic retinopathy, take other medications to treat type 2 diabetes such as sulfonylureas or insulin, have mental health issues including depression or suicidal thoughts
Strategies like eating adequate protein, getting enough fiber, and staying well hydrated can help support appetite control and satiety
So if you cant receive semaglutide, what should you receive